Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
- Posgrado modular en Ciruga Periodontal (Dr
(NYSE: PFE) announced positive topline results from the phase 2b VESPER-3 study investigating monthly maintenance dosing of its fully-biased, ultra-long-acting, injectable GLP-1 receptor agonist (RA) PF3944 (MET-097i) in adults with obesity or overweight without type 2 diabetes
By integrating genomics, transcriptomics, and proteomics analyses of G6PD-associated disorders, a novel area of G6PD research may be explored
Common sample pretreatment techniques like derivatization and SPE are discussed for their efficacy in improving detection sensitivity and selectivity
US$ 27.17
US$ 26.00
US$ 29.50
US$ 26.74
US$ 23.39
US$ 24.24
US$ 28.45
